Medical Doctor Program year 2023 Reported 2019–2023 Source: CMS Open Payments, 2026 publication

Connor Haugh

Clinical Cardiac Electrophysiology Manchester, NH Medical Doctor

NPI 1114904950 CMS profile 1106911

100 McGregor St, Manchester, NH 03102

Open in the dashboard

General payments

$25,160

59 records reported · program years 2019–2023

Research payments

$0

Paid to them · None reported · program years 2019–2023

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$8,325 paid to institutions, not to them · program years 2019–2020

Through program year 2023, Connor Haugh of Manchester, NH is reported in the CMS Open Payments database as having received $25,160 across 59 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $8,325 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 57th percentile of Clinical Cardiac Electrophysiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2023 General $2,868 5
2022 General $3,645 14
2021 General $2,190 6
2020 General $7,146 13
2019 General $9,310 21

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Connor Haugh
  • Clinical Cardiac Electrophysiology median
  • Middle half of Clinical Cardiac Electrophysiology
  • National median

In program year 2025, general payments to Connor Haugh were reported at $0. Among 3,064 Clinical Cardiac Electrophysiology profiles paid that year, the median was $2,462 and the middle half received between $733 and $7,710.

Show as a table
Year Connor Haugh Clinical Cardiac Electrophysiology median Middle half National median
2019 $9,310 $2,361 $585–$8,260 $163
2020 $7,146 $993 $247–$4,351 $114
2021 $2,190 $1,185 $326–$4,739 $132
2022 $3,645 $2,073 $554–$6,789 $149
2023 $2,868 $2,568 $759–$8,159 $160
2024 $0 $2,557 $703–$7,403 $164
2025 $0 $2,462 $733–$7,710 $169

Breakdown

Who paid General payments · program years 2019–2023
  1. Boston Scientific Corporation $18,675 37 payments
  2. Abbott Laboratories $3,915 15 payments
  3. Medtronic Vascular, Inc. $2,135 2 payments
  4. Atricure, Inc. $142 1 payment
  5. Biotronik Inc. $135 1 payment
  6. Biosense Webster, Inc. $118 1 payment
  7. Janssen Pharmaceuticals, Inc $24 1 payment
  8. Cardiva Medical, Inc. $15 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2023
  1. Consulting Fee $20,694 8 payments
  2. Food and Beverage $2,939 43 payments
  3. Travel and Lodging $1,527 8 payments
Products named General payments · program years 2019–2023
  1. General - Therapies Therapies $4,767 8 payments
  2. General Therapies Therapies $4,087 4 payments
  3. Ensite Cardiac Mapping System $3,056 1 payment
  4. General - Therapies General - Therapies_EP $3,000 1 payment
  5. GENERAL THERAPIES Pain Management $2,013 1 payment
  6. GENERAL THERAPIES General Therapies $1,469 8 payments
  7. Confirm Rx $177 1 payment
  8. CardioMEMS HF System $150 1 payment
  9. ASSURITY $150 6 payments
  10. ViewFlex Xtra ICE Catheter $148 1 payment
  11. Other $1,257 24 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 14 drugs

Part D claims

415

Median for Cardiology: 2,533

Drug cost

$200,445

Median for Cardiology: $485,213

Branded share of claims

50.4%

Median for Cardiology: 25.7%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Eliquis Apixaban Brand 143 $164,051
Xarelto Rivaroxaban Brand 20 $20,176
Entresto Sacubitril/Valsartan Brand 13 $12,002
Flecainide Acetate Generic 31 $1,997
Metoprolol Succinate Generic 61 $616
Sotalol Sotalol Hcl Brand 18 $503
Amiodarone Hcl Generic 19 $352
Diltiazem 24hr Er (Cd) Diltiazem Hcl Brand 15 $273
Amlodipine Besylate Generic 18 $123
Lisinopril Generic 20 $108

The 10 drugs with the highest cost, of 14 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,782 Part D prescribers listed as Cardiology; they describe a distribution and say nothing about conduct.

Records

59 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Clinical Cardiac Electrophysiology in New Hampshire

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2023

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record